SELEX methods on the road to protein targeting with nucleic acid aptamers P Bayat, R Nosrati, M Alibolandi, H Rafatpanah, K Abnous, M Khedri, ... Biochimie 154, 132-155, 2018 | 219 | 2018 |
Detection of food-born allergens with aptamer-based biosensors M Khedri, M Ramezani, H Rafatpanah, K Abnous TrAC Trends in Analytical Chemistry 103, 126-136, 2018 | 62 | 2018 |
Cancer immunotherapy via nucleic acid aptamers M Khedri, H Rafatpanah, K Abnous, P Ramezani, M Ramezani International immunopharmacology 29 (2), 926-936, 2015 | 55 | 2015 |
Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways A Tajbakhsh, M Hasanzadeh, M Rezaee, M Khedri, M Khazaei, ... Journal of cellular physiology 233 (3), 2183-2192, 2018 | 52 | 2018 |
An aptamer for recognizing the transmembrane protein PDL-1 (programmed death-ligand 1), and its application to fluorometric single cell detection of human ovarian carcinoma cells R Yazdian-Robati, M Ramezani, M Khedri, N Ansari, K Abnous, ... Microchimica Acta 184, 4029-4035, 2017 | 39 | 2017 |
Morphine attenuated the cytotoxicity induced by arsenic trioxide in H9c2 cardiomyocytes H Amini-Khoei, MJ Hosseini, M Momeny, M Rahimi-Balaei, S Amiri, ... Biological trace element research 173, 132-139, 2016 | 18 | 2016 |
The immunopathobiology of T cells in stress condition: a review M Khedri, A Samei, M Fasihi-Ramandi, RA Taheri Cell Stress and Chaperones 25, 743-752, 2020 | 16 | 2020 |
Development and evaluation of novel aptamers specific for human PD1 using hybrid systematic evolution of ligands by exponential enrichment approach M Khedri, K Abnous, H Rafatpanah, MS Nabavinia, SM Taghdisi, ... Immunological Investigations 49 (5), 535-554, 2020 | 13 | 2020 |
An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal M Khedri, K Abnous, H Rafatpanah, M Ramezani Journal of Receptors and Signal Transduction 38 (1), 31-36, 2018 | 9 | 2018 |
Gut microbiota modulates the efficiency of programmed cell death protein 1 cancer immunotherapies A Samei, M Khedri Iranian Journal of Allergy, Asthma and Immunology, 2022 | 3 | 2022 |
Rapamycin attenuates gene expression of programmed cell death protein-ligand 1 and Foxp3 in the brain; a novel mechanism proposed for immunotherapy in the brain M Khedri, H Kooshki, RA Taheri Research in Pharmaceutical Sciences 16 (2), 165-172, 2021 | 2 | 2021 |
Redox-Active Bacteria Alleviated Ethylene Glycol-Induced Kidney Calculi in Rats M Khedri, M Zamani Boldaji, T Mazouji Translational Research in Urology 6 (2), 91-96, 2024 | | 2024 |
The effect of redox bacteria on the programmed cell death-1 cancer immunotherapy M Nejati, M Soheili, M Salami, M Khedri Research in Pharmaceutical Sciences 19 (2), 228-237, 2024 | | 2024 |